# Two-level ESPB in Total Knee Arthroplasty

> **NCT06470542** · PHASE4 · COMPLETED · sponsor: **Poznan University of Medical Sciences** · enrollment: 60 (actual)

## Conditions studied

- Knee Osteoarthritis
- Knee Pain Chronic
- Knee Arthritis

## Interventions

- **DRUG:** 2 x 20 ml of Ropivacaine 0.2% Injectable Solution
- **DRUG:** 2 x 20ml of Ropivacaine 0.2% Injectable Solution

## Key facts

- **NCT ID:** NCT06470542
- **Lead sponsor:** Poznan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-07
- **Primary completion:** 2025-08-05
- **Final completion:** 2025-08-05
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06470542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06470542, "Two-level ESPB in Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06470542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*